M.L.A. (Marie-Louise) Schuttelaar

Dermatologist

M.L.A. (Marie-Louise) Schuttelaar
E-mail:
m.l.a.schuttelaar umcg.nl

Research

Publications
  1. Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

    Ariëns, L. F. M., van der Schaft, J., Bakker, D. S., Balak, D., Romeijn, M. L. E., Kouwenhoven, T., Kamsteeg, M., Giovannone, B., Drylewicz, J., van Amerongen, C. C. A., Delemarre, E. M., Knol, E. F., van Wijk, F., Nierkens, S., Thijs, J. L., Schuttelaar, M. L. A. & de Bruin-Weller, M. S., Jan-2020, In : Allergy. 75, 1, p. 116-126 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Occupationally relevant positive patch test reactions in Indonesian Batik workers

    Febriana, S. A., Ridora, Y., Indrastuti, N., Waskito, F. & Schuttelaar, M. L. A., 28-Feb-2020, In : CONTACT DERMATITIS. 3 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Cheilitis caused by contact allergy to toothpaste containing stannous (tin) - two cases

    van Amerongen, C. C. A., de Groot, A., Volkering, R. & Schuttelaar, M. L. A., 13-Apr-2020, In : CONTACT DERMATITIS. 4 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

  4. A survey of members of the European Surveillance System on Contact Allergy and the EU project "StanDerm" to identify allergens tested in cosmetic series across Europe

    Horton, E., Wilkinson, M., Aalto-Korte, K., Pesonen, M., Bauer, A., Chowdhury, M. M. U., Cooper, S., Cousen, P., Crepy, M-N., Filon, F. L. F., Gallo, R., Geier, J., Gimenez-Arnau, A., Goncalo, M., Goossens, A., Green, C., Guarneri, F., Hadzavdic, S. L., Johansen, J. D., Johnston, G. A., Rustemeyer, T., Sanchez-Perez, J., Thyssen, J. P., Schuttelaar, M-L. A., Stone, N. & Uter, W., Mar-2020, In : CONTACT DERMATITIS. 82, 3, p. 195-200 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

    Deleuran, M., Thaci, D., Beck, L. A., de Bruin-Weller, M., Blauvelt, A., Forman, S., Bissonnette, R., Reich, K., Soong, W., Hussain, I., Foley, P., Hide, M., Bouaziz, J-D., Gelfand, J. M., Sher, L., Schuttelaar, M. L. A., Wang, C., Chen, Z., Akinlade, B., Gadkari, A., Eckert, L., Davis, J. D., Rajadhyaksha, M., Staudinger, H., Graham, N. M. H., Pirozzi, G. & Ardeleanu, M., Feb-2020, In : Journal of the American Academy of Dermatology. 82, 2, p. 377-388 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (178) »

Activities
  1. Therapieresistent handeczeem

    Marielouise Schuttelaar (Invited speaker)
    8-Nov-2019

    Activity: Talk or presentationAcademic

  2. 10th Georg Rajka International Symposium on Atopic Dermatitis (ISAD2018)

    Marielouise Schuttelaar (Member of programme committee)
    11-Apr-201813-Apr-2018

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

View all (7) »

ID: 13655818